Melflufen plus dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM) exposed or refractory to prior alkylators: a pooled analysis of the O-12-M1 and HORIZON studies

Autores: Rodríguez Otero, Paula; Mateos, M. V.; Oriol, A.; Larocca, A.; Blade, J. ; Cavo, M.; Leleu, X. ; Nadeem, O.; Hiemenz, J. W.; Touzeau, C.; Alegre, A.; Paner, A.; Maisel, C.; Mazumder, A.; Raptis, A.; Thuresson, M. ; Harmenberg, J.; Harlin, O.; Richardson, P. G.